Cargando…
Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT
BACKGROUND: Paclitaxel has shown significant anti-tumor activity against non-small cell lung cancer (NSCLC); however, resistance to paclitaxel frequently occurs and represents a significant clinical problem and its underlying molecular mechanism remains elusive. METHODS: Long-term treatment of cultu...
Autores principales: | Cai, Yuanming, Jia, Ruxue, Xiong, Haozhe, Ren, Qun, Zuo, Weimin, Lin, Tingting, Lin, Rong, Lei, Yan, Wang, Ping, Dong, Huiyue, Zhao, Hu, Zhu, Ling, Fu, Yunfeng, Zeng, Zhiyong, Zhang, Wei, Wang, Shuiliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689126/ https://www.ncbi.nlm.nih.gov/pubmed/31496800 http://dx.doi.org/10.2147/CMAR.S215427 |
Ejemplares similares
-
Integrative Gene Expression Profiling Reveals That Dysregulated Triple microRNAs Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer via Cotargeting MAPT [Corrigendum]
Publicado: (2020) -
Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs
por: Lin, Tingting, et al.
Publicado: (2019) -
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
por: Park, Susanna B, et al.
Publicado: (2014) -
MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer
por: Wang, Shuiliang, et al.
Publicado: (2016) -
Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers
por: Pan, Yiyuan, et al.
Publicado: (2018)